Banks deliberate pros and cons of $30bn ChemChina loan

By Shruti Chaturvedi
17 Mar 2016

The Asian syndication of a jumbo loan to back China National Chemical Corp’s (ChemChina) acquisition of Syngenta is seeing interest from many international lenders in Asia. Banks are weighing the benefits of the borrower’s state ownership against the weakness of its financials on a standalone basis, writes Shruti Chaturvedi.

State-owned ChemChina is understood to be looking for a $30bn financing package in Asia to back its $43bn acquisition of Swiss seed maker Syngenta, first announced in early February.

Of the $30bn, half will be via a loan marketed primarily to banks, while the remaining will be ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial